BFS
AXSM icon

Bare Financial Services’s Axsome Therapeutics AXSM Stock Holding History

Bare Financial Services’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92K Hold
16
– – ﹤0.01% 943
2026
Q1 		$2.7K Hold
16
– – ﹤0.01% 879
2025
Q4 		$2.92K Sell
16
-5
-24% -$698 ﹤0.01% 736
2025
Q3 		$2.55K Buy
21
+11
+110% +$1.24K ﹤0.01% 751
2025
Q2 		$1.04K Buy
+10
New +$1.06K ﹤0.01% 912

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Bare Financial Services's AXSM Position: Q2 2026 in Review

Bare Financial Services held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 16 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Bare Financial Services first reported a position in AXSM in Q2 2025 and has held it in 5 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Bare Financial Services held 16 shares of Axsome Therapeutics worth $3.92K as of Q2 2026.
  • Bare Financial Services left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Bare Financial Services's portfolio in Q2 2026, its #943 holding.
  • Bare Financial Services first reported a position in Axsome Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Bare Financial Services's 13F filing for Q2 2026, filed 27 Jul 2026.